Not sure why you are tagging them instead of just the links to their post but a quick research of IHL show the company are in clinical trials for 6 products which all have a big market whereas wheezo is already in commercialisation for a product which has a small niche market as evidence by the commercialsation in Australia.
Like I told you $10 per month isn't even that expense in Australia, yet you don't seem to be concern with this massive discrepancy between the 1.2K units sales last year but out of them only 10 subscription for the following year.
RSH Price at posting:
5.7¢ Sentiment: Hold Disclosure: Not Held
